Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Journal of Community Hospital Internal Medicine Perspectives|September 6, 2018
Diabetic nephropathy: newer therapeutic perspectivesKrishna C Keri, Naga S Samji, Samuel BlumenthalPostgraduate Medical Journal|January 27, 2019
Primary membranous nephropathy: comprehensive review and historical perspectiveKrishna C Keri, Samuel Blumenthal, Varsha Kulkarni, et al.Journal of Clinical and Experimental Hepatology|September 14, 2019
Magnitude of Nonalcoholic Fatty Liver Disease: Western PerspectiveNaga S Samji, Rajanshu Verma, Sanjaya K SatapathyBMC Research Notes|June 9, 2018
Urinary exosomal expression of activator of G protein signaling 3 in polycystic kidney diseaseKrishna C Keri, Kevin R Regner, Aaron T Dall, et al.Hemodialysis International. International Symposium on Home Hemodialysis|September 30, 2005
Phosphorus-enriched hemodialysis during pregnancy: Two case reportsSyed Hussain, Virginia Savin, Walter Piering, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 28, 2006
A multicenter, randomized, double-blind, placebo-controlled, dose-ranging study of AST-120 (Kremezin) in patients with moderate to severe CKDGerald Schulman, Rajiv Agarwal, Muralidhar Acharya, et al.Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Cinacalcet hydrochloride (Sensipar) in hemodialysis patients on active vitamin D derivatives with controlled PTH and elevated calcium x phosphateGlenn M Chertow, Samuel Blumenthal, Stewart Turner, et al.Kidney International Reports|November 20, 2018
Effect of PF-04634817, an Oral CCR2/5 Chemokine Receptor Antagonist, on Albuminuria in Adults with Overt Diabetic NephropathyJeremy D Gale, Steven Gilbert, Samuel Blumenthal, et al.Kidney International|August 26, 2004
Iron sucrose in hemodialysis patients: safety of replacement and maintenance regimensGeorge R Aronoff, William M Bennett, Samuel Blumenthal, et al.Journal of the American Society of Nephrology : JASN|October 29, 2011
Pyridorin in type 2 diabetic nephropathyEdmund J Lewis, Tom Greene, Samuel Spitalewiz, et al.Pageof 2